Alignment Healthcare, Inc. (ALHC)

NASDAQ

$20.11

+$0.75 (3.87%)

Today

No price data available for this timeframe.

Key Statistics

Day Range

$19.31$20.29

Open $19.36

52 Week Range

$10.18$21.06

Previous Close $19.36

Market Cap4.02B

Volume2.89M

Avg Volume2.83M

P/E (TTM)-192.34

EPS (TTM)$-0.10

Dividend / YieldN/A

Dividend StreakN/A

Analyst Ratings & Targets

Price Target

Consensus Target

$19.75

Based on 7 analysts (last year)

High Target

$22.00

Low Target

$18.00

Current

$20.11

Target

$19.75

$18.00$22.00

Potential downside of -1.79%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$19.75

4 analysts

Last Year

$18.57

7 analysts

All Time

$14.38

13 analysts

Analyst Consensus

Current Consensus

Buy

Based on 16 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

D+

(Score: 1)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 3, 2025	Scott Fidel	Goldman Sachs	$22.00	$16.86	+30.49%
Oct 31, 2025	Unknown	Barclays	$18.00	$16.88	+6.67%
Oct 31, 2025	Kevin Caliendo	UBS	$18.00	$18.53	-2.86%
Oct 14, 2025	Unknown	Goldman Sachs	$21.00	$17.31

Recent Analyst Actions


Nov 24, 2025	Upgrade	JP Morgan	Neutral	Overweight
Nov 5, 2025	Maintained	JP Morgan	Neutral	Neutral
Nov 3, 2025	Maintained	Barclays	Equal Weight	Equal Weight
Oct 31, 2025	Maintained	UBS	Neutral	Neutral
Aug 25, 2025	Upgrade	Keybanc	Sector Weight	Overweight

Showing 1 to 5 of 107 entries

Analyst Ratings & Targets

Price Target

Consensus Target

$19.75

Based on 7 analysts (last year)

High Target

$22.00

Low Target

$18.00

Current

$20.11

Target

$19.75

$18.00$22.00

Potential downside of -1.79%

Based on consensus price target

Price Target Timeframes

Last Month

$0.00

0 analysts

Last Quarter

$19.75

4 analysts

Last Year

$18.57

7 analysts

All Time

$14.38

13 analysts

Analyst Consensus

Current Consensus

Buy

Based on 16 analyst ratings

Strong BuyBuyHoldSellStrong Sell

Stock Valuation Score

Rating:

D+

(Score: 1)

DCFDiscounted Cash Flow - Evaluates fair stock value based on expected future cash flows1/5

ROEReturn On Equity - Measures profitability relative to shareholders' equity1/5

ROAReturn On Assets - Shows how efficiently a company uses its assets to generate profits1/5

D/EDebt to Equity - Ratio comparing company's debt to its shareholders' equity

Recent Price Target Updates

Date	Analyst	Firm	Target	Price	Upside
Nov 3, 2025	Scott Fidel	Goldman Sachs	$22.00	$16.86	+30.49%
Oct 31, 2025	Unknown	Barclays	$18.00	$16.88	+6.67%
Oct 31, 2025	Kevin Caliendo	UBS	$18.00	$18.53	-2.86%
Oct 14, 2025	Unknown	Goldman Sachs	$21.00	$17.31

Recent Analyst Actions


Nov 24, 2025	Upgrade	JP Morgan	Neutral	Overweight
Nov 5, 2025	Maintained	JP Morgan	Neutral	Neutral
Nov 3, 2025	Maintained	Barclays	Equal Weight	Equal Weight
Oct 31, 2025	Maintained	UBS	Neutral	Neutral
Aug 25, 2025	Upgrade	Keybanc	Sector Weight	Overweight

Showing 1 to 5 of 107 entries